重症患者血清乳酸动力学的预后意义
该研究分析了德国一家ICU的2191例入院乳酸>2.0 mmol/L的患者,共26,285次乳酸测量,用第1天和第2天最高乳酸浓度计算24小时乳酸变化(Δ24Lac),回顾性随访院内和长期死亡率。Δ24Lac作为连续变量每升高1%,院内死亡风险降低(HR 0.987,95%CI 0.985-0.990,p<0.001);Youden指数确定最佳截断值为19%。Δ24Lac≤19%与院内死亡率升高(15% vs 43%;OR 4.11,95%CI 3.23-5.21,p<0.001)和长期死亡率升高(HR 1.54,95%CI 1.28-1.87,p<0.001)相关,校正APACHE II、儿茶酚胺需求和插管后仍显著。作者认为Δ24Lac可能是一个独立、易获取且重要的重症患者风险分层参数。
要点
- 入院乳酸>2.0 mmol/L的重症患者,24小时乳酸下降幅度(Δ24Lac)≤19%与院内死亡率升高相关(15% vs 43%;OR 4.11,95%CI 3.23-5.21,p<0.001)。
- Δ24Lac作为连续变量,每升高1%院内死亡风险降低(HR 0.987,95%CI 0.985-0.990,p<0.001)。
- Δ24Lac≤19%与长期死亡率升高相关(HR 1.54,95%CI 1.28-1.87,p<0.001),校正APACHE II、儿茶酚胺需求和插管后仍显著。
- 按APACHE II评分、基线乳酸水平和性别匹配256例Δ24Lac≤19%患者与对照后,Δ24Lac≤19%仍与院内和长期生存率降低相关。
- Δ24Lac可能作为独立、易获取的重症患者风险分层参数(作者结论)。
适用人群与场景
- 德国一家ICU收治的成人重症患者,纳入标准为入院时乳酸浓度>2.0 mmol/L。
- 共2191例患者,26,285次乳酸测量。
诊断标准与关键阈值
- 入院乳酸浓度>2.0 mmol/L为纳入标准。
- Δ24Lac由第1天和第2天最高乳酸浓度计算。
- 通过Youden指数计算的最佳Δ24Lac截断值为19%。
研究设计与关键结果
- 研究类型:回顾性分析(随访为回顾性),单中心(德国一家ICU),2191例入院乳酸>2.0 mmol/L的重症患者,共26,285次乳酸测量。
- Δ24Lac较低的患者年龄相似但临床病情更重。
- Δ24Lac作为连续变量:每升高1%,院内死亡风险降低(HR 0.987,95%CI 0.985-0.990,p<0.001)。
- Δ24Lac≤19% vs >19%:院内死亡率15% vs 43%(OR 4.11,95%CI 3.23-5.21,p<0.001)。
- Δ24Lac≤19% vs >19%:长期死亡率HR 1.54(95%CI 1.28-1.87,p<0.001),校正APACHE II、儿茶酚胺需求和插管后仍显著。
- 匹配分析:256例Δ24Lac≤19%患者与按APACHE II评分、基线乳酸水平和性别校正的对照匹配,Δ24Lac≤19%仍与院内和长期生存率降低相关。
证据类型、等级与局限
- 证据类型:回顾性分析(单中心,德国一家ICU)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于入院乳酸>2.0 mmol/L的重症患者,计算24小时乳酸下降幅度(Δ24Lac)可能有助于风险分层;Δ24Lac≤19%提示院内和长期死亡风险较高(作者认为Δ24Lac可能构成独立、易获取且重要的风险分层参数)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Changes of lactate concentration over time were reported to be associated with survival in septic patients. We aimed to evaluate delta-lactate (ΔLac) 24 h after admission (Δ24Lac) to an intensive care unit (ICU) in critically ill patients for short- and long-term prognostic relevance.
METHODS: In total, 26,285 lactate measurements of 2191 patients admitted to a German ICU were analyzed. Inclusion criterion was a lactate concentration at admission above 2.0 mmol/L. Maximum lactate concentrations of day 1 and day 2 were used to calculate Δ24Lac. Follow-up of patients was performed retrospectively. Association of Δ24Lac and both in-hospital and long-term mortality were investigated. An optimal cut-off was calculated by means of the Youden index.
RESULTS: Patients with lower Δ24Lac were of similar age, but clinically sicker. As continuous variable, higher Δ24Lac was associated with decreased in-hospital mortality (per 1% Δ24Lac; HR 0.987 95%CI 0.985-0.990; p < 0.001) and an optimal Δ24Lac cut-off was calculated at 19%. Δ24Lac ≤ 19% was associated with both increased in-hospital (15% vs 43%; OR 4.11; 95%CI 3.23-5.21; p < 0.001) and long-term mortality (HR 1.54 95%CI 1.28-1.87; p < 0.001), even after correction for APACHE II, need for catecholamines and intubation. We matched 256 patients with Δ24Lac ≤ 19% to case-controls > 19% corrected for APACHE II scores, baseline lactate level and sex: Δ24Lac ≤ 19% remained associated with lower in-hospital and long-term survival.
CONCLUSIONS: Lower Δ24Lac was robustly associated with adverse outcome in critically ill patients, even after correction for confounders. Δ24Lac might constitute an independent, easily available and important parameter for risk stratification in the critically ill.
参考来源
- Masyuk M, Wernly B, Lichtenauer M, et al. Prognostic relevance of serum lactate kinetics in critically ill patients. Intensive Care Med. 2018. PMID: 30478622. doi:10.1007/s00134-018-5475-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。